Douglas Hanlon
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Dermatology top 2%
- Epidemiology
- Co-authors
- Richard L. EdelsonVirginia CodyW. Mark SaltzmanCarole L. BergerHong ShenPeter CresswellAnne L. AckermanAlessandra Giodini
- Topics
- Immunotherapy and Immune Responses (27 papers)CAR-T cell therapy research (13 papers)Immune Cell Function and Interaction (9 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Douglas Hanlon
37 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Immunology 894
- Molecular Biology 598
- Oncology 318
- Dermatology 291
- Epidemiology 214
Countries citing papers authored by Douglas Hanlon
This map shows the geographic impact of Douglas Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Hanlon more than expected).
Fields of papers citing papers by Douglas Hanlon
This network shows the impact of papers produced by Douglas Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Hanlon. The network helps show where Douglas Hanlon may publish in the future.
Co-authorship network of co-authors of Douglas Hanlon
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Hanlon. A scholar is included among the top collaborators of Douglas Hanlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Hanlon. Douglas Hanlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 53 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 44 | |
| 6 | 21 | |
| 7 | 26 | |
| 8 | 21 | |
| 9 | 41 | |
| 10 | 22 | |
| 11 | 86 | |
| 12 | 80 | |
| 13 | 324 | |
| 14 | 13 | |
| 15 | 53 | |
| 16 | 1 | |
| 17 | 34 | |
| 18 | 30 | |
| 19 | 1 | |
| 20 | 2 |
About Douglas Hanlon
Douglas Hanlon is a scholar working on Immunology, Dermatology and Oncology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), CAR-T cell therapy research (13 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Immunology (894 citations), Dermatology (291 citations) and Pharmaceutical Science (85 citations). Douglas Hanlon has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Richard L. Edelson, Virginia Cody, W. Mark Saltzman, Carole L. Berger, Hong Shen, Peter Cresswell, Anne L. Ackerman, Alessandra Giodini, Ella R. Hinson and Jennifer K. Saucier-Sawyer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.